US Stock MarketDetailed Quotes

KA Kineta

Watchlist
  • 0.452
  • -0.035-7.19%
Close May 17 16:00 ET
  • 0.460
  • +0.008+1.66%
Post 19:32 ET
5.54MMarket Cap-322P/E (TTM)

About Kineta Company

Kineta, Inc. is a clinical-stage biotechnology company, which develops immunotherapies for cancer patients. Its immuno-oncology focused platform aims at developing fully human antibodies to address the major mechanisms of cancer immune resistance. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA.

Company Profile

SymbolKA
Company NameKineta
Listing DateFeb 11, 2016
Founded2008
CEOMr. Shawn Iadonato, Pd.D
MarketNASDAQ
Employees11
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address219 Terry Avenue North,Suite 300
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98109
Phone1-206-378-0400
Websitehttp://www.kinetabio.com

Company Executives

  • Name
  • Position
  • Salary
  • Thierry Guillaudeux
  • Chief Scientific Officer
  • --
  • Keith A. Baker
  • Chief Financial Officer and Treasurer
  • 813.69K
  • Craig W. Philips
  • President and Secretary
  • 993.40K
  • Dr. Shawn Iadonato, Pd.D
  • Director
  • 1.28M
  • Marion R. Foote
  • Independent Director
  • 90.12K
  • David A. Arkowitz, M.B.A.
  • Independent Director
  • 141.55K
  • Raymond Bartoszek
  • Independent Director
  • 86.37K
  • Dr. Scott Dylla, PhD
  • Independent Director
  • 66.10K
  • Dr. Richard Peters, M.D.,PhD
  • Lead Independent Director
  • 148.18K
  • Dr. Kimberlee Cobleigh Drapkin, PhD
  • Independent Director
  • 69.85K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg